
Quarterly report 2025-Q2
added 07-31-2025
Cognex Corporation Financial Ratios 2011-2025 | CGNX
Annual Financial Ratios Cognex Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
55.2 | 58.2 | 44.8 | 49.0 | 76.8 | 44.5 | 35.1 | 62.1 | 38.3 | 14.9 | 26.3 | 45.4 | 24.9 | 24.9 |
P/S |
6.4 | 7.9 | 9.6 | 13.2 | 16.7 | 12.5 | 9.5 | 14.7 | 11.0 | 6.2 | 6.6 | 9.4 | 5.2 | 5.4 |
EPS |
0.6 | 0.7 | 1.2 | 1.6 | 1.0 | 1.2 | 1.3 | 1.0 | 0.8 | 1.1 | 1.4 | 0.8 | 0.8 | 0.8 |
EV (Enterprise Value) |
6.15 B | 6.9 B | 10 B | 14.1 B | 13.8 B | 9.44 B | 7.74 B | 11.1 B | 5.72 B | 2.79 B | 3.22 B | 3.37 B | 1.7 B | 1.76 B |
EBITDA per Share |
0.8 | 0.86 | 1.51 | 1.88 | 1.11 | 0.978 | 1.41 | 1.59 | 1.03 | 0.786 | 0.899 | 0.561 | 0.55 | 0.568 |
EV/EBITDA |
42.1 | 60.3 | 53.2 | 31.3 | 39.4 | 32.1 | 20.1 | 20.1 | 33.9 | 17.5 | 17.9 | |||
PEG |
21.03 | -27.88 | 10.71 | 2.57 | 6.73 | -7.07 | 1.45 | 3.68 | -1.98 | 0.27 | 0.41 | 6.57 | -5.19 | 2.95 |
P/B |
3.9 | 4.4 | 6.7 | 9.6 | 10.7 | 6.7 | 6.8 | 10.0 | 5.9 | 3.4 | 4.3 | 5.2 | 3.0 | 3.1 |
P/CF |
39.3 | 58.3 | 39.7 | 43.7 | 55.8 | 39.2 | 41.3 | 56.3 | 33.8 | 31.0 | 23.6 | 40.7 | 18.6 | 22.2 |
ROE % |
7.00 | 7.53 | 14.98 | 19.57 | 13.96 | 15.04 | 19.31 | 16.18 | 15.54 | 22.66 | 16.50 | 11.43 | 11.90 | 12.63 |
ROA % |
5.33 | 5.61 | 11.01 | 13.97 | 9.78 | 10.81 | 17.00 | 13.76 | 14.40 | 21.07 | 14.78 | 10.37 | 10.85 | 11.42 |
ROCE % |
7.58 | 8.69 | 17.12 | 22.03 | 13.51 | 8.08 | 18.45 | 22.07 | 16.53 | 14.58 | 19.39 | 13.31 | 14.44 | 15.30 |
Current Ratio |
4.2 | 3.9 | 3.8 | 3.5 | 3.3 | 5.0 | 8.5 | 5.6 | 8.0 | 8.4 | 3.3 | 5.4 | 4.8 | 5.3 |
DSO |
51.4 | 52.2 | 46.4 | 45.1 | 51.6 | 54.4 | 57.7 | 61.9 | 40.4 | 34.7 | 38.2 | 54.7 | 47.7 | 54.7 |
DIO |
202.2 | 219.9 | 151.3 | 114.5 | 107.1 | 115.9 | 147.5 | 147.0 | 85.2 | 132.9 | 107.2 | 111.5 | 120.2 | 131.6 |
DPO |
37.6 | 37.5 | 45.7 | 39.7 | 30.2 | 34.4 | 28.7 | 50.8 | 31.0 | 28.0 | 57.6 | 41.2 | 31.3 | 33.2 |
Operating Cycle |
253.5 | 272.1 | 197.7 | 159.5 | 158.6 | 170.4 | 205.2 | 208.9 | 125.6 | 167.6 | 145.4 | 166.2 | 167.9 | 186.3 |
Cash Conversion Cycle |
215.9 | 234.6 | 152.0 | 119.8 | 128.4 | 136.0 | 176.5 | 158.1 | 94.6 | 139.6 | 87.8 | 125.0 | 136.6 | 153.0 |
All numbers in USD currency
Quarterly Financial Ratios Cognex Corporation
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.24 | 0.14 | - | 0.17 | 0.21 | 0.07 | - | 0.11 | 0.33 | 0.15 | - | 0.2 | 0.34 | 0.39 | - | - | - | - | 0.4 | 0.5 | -0.01 | 0.12 | 0.47 | 0.24 | 0.28 | 0.19 | 0.47 | 0.24 | 0.28 | 0.19 | 0.26 | 0.47 | 0.33 | 0.21 | - | 0.63 | 0.5 | 0.18 | - | 1.21 | 0.5 | 0.24 | - | 0.58 | 0.3 | 0.21 | - | 0.24 | 0.19 | 0.18 | - | 0.21 | 0.46 | 0.34 | - | 0.43 | 0.46 | 0.33 |
EBITDA per Share |
- | 0.19 | - | - | - | 0.11 | - | - | - | 0.15 | - | 0.3 | 0.38 | 0.52 | - | 0.57 | 0.52 | 0.47 | 0.34 | 0.65 | 0.03 | 0.15 | 0.1 | 0.34 | 0.36 | 0.21 | 0.1 | 0.33 | 0.35 | 0.2 | 0.26 | 0.51 | 0.4 | 0.22 | - | 0.74 | 0.65 | 0.22 | - | 0.41 | 0.65 | 0.28 | - | 0.71 | 0.35 | 0.28 | - | 0.33 | 0.27 | 0.23 | - | 0.31 | 0.62 | 0.45 | - | 0.63 | 0.64 | 0.45 |
ROE % |
8.10 | 7.81 | 5.10 | 6.37 | 5.75 | 7.23 | 6.92 | 9.37 | 10.55 | 10.90 | 11.64 | 16.92 | 19.76 | 20.95 | 15.86 | 21.35 | 23.00 | 17.48 | 13.96 | 14.39 | 10.53 | 14.22 | 15.04 | 16.19 | 16.79 | 17.48 | 17.96 | 15.03 | 18.70 | 19.53 | 20.01 | 21.44 | 19.68 | 18.99 | 11.56 | 24.17 | 31.21 | 32.06 | 20.39 | 27.23 | 21.46 | 19.69 | 12.88 | 16.10 | 12.47 | 11.56 | 8.25 | 11.36 | 11.25 | 12.10 | 9.06 | 12.32 | 12.47 | 12.47 | 9.18 | 3.26 | 3.45 | 2.47 |
ROA % |
6.11 | 5.90 | 3.84 | 4.79 | 4.31 | 5.37 | 5.12 | 6.91 | 7.75 | 8.36 | 8.75 | 12.60 | 11.18 | 15.02 | 11.34 | 15.19 | 16.20 | 12.31 | 9.78 | 10.19 | 7.54 | 10.19 | 10.81 | 12.78 | 13.80 | 15.00 | 15.81 | 13.11 | 16.12 | 16.70 | 17.03 | 18.67 | 17.59 | 17.34 | 10.72 | 22.45 | 29.01 | 29.81 | 18.96 | 25.09 | 19.50 | 17.73 | 11.54 | 14.46 | 11.25 | 10.46 | 7.49 | 10.32 | 10.24 | 11.02 | 8.26 | 11.21 | 11.32 | 11.29 | 8.30 | 2.95 | 3.12 | 2.23 |
ROCE % |
8.72 | 8.39 | 5.52 | 7.58 | 7.62 | 9.47 | 7.99 | 10.87 | 11.70 | 11.98 | 13.95 | 19.81 | 22.80 | 24.59 | 18.12 | 22.80 | 24.60 | 17.63 | 13.51 | 10.13 | 5.65 | 9.95 | 10.52 | 10.77 | 11.39 | 12.13 | 12.56 | 15.14 | 18.45 | 19.68 | 20.18 | 21.72 | 20.28 | 19.65 | 12.52 | 15.97 | 13.76 | 14.87 | 12.40 | 19.91 | 23.98 | 21.24 | 14.10 | 17.73 | 13.84 | 13.44 | 9.56 | 13.37 | 13.54 | 14.49 | 10.99 | 15.04 | 15.28 | 15.55 | 11.54 | 4.05 | 4.35 | 3.14 |
Current Ratio |
4.0 | 4.0 | 4.2 | 4.2 | 4.0 | 3.8 | 3.9 | 4.0 | 3.9 | 3.7 | 3.8 | 3.7 | - | 3.4 | 3.5 | 3.7 | 3.4 | 3.5 | 3.3 | 3.3 | 3.3 | 3.3 | 3.6 | 3.6 | 3.6 | 3.6 | 8.3 | 8.3 | 8.3 | 8.3 | 6.7 | 6.7 | 6.7 | 6.7 | 13.7 | 13.7 | 13.7 | 13.7 | 14.3 | 14.3 | 14.3 | 14.3 | 9.6 | 9.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
63.2 | 64.3 | - | 61.7 | 56.8 | 54.7 | - | 64.4 | 54.9 | 61.1 | - | 21.0 | 25.8 | 46.1 | - | 44.7 | 47.1 | 48.6 | 51.3 | 45.7 | 67.8 | 62.5 | 55.6 | 51.5 | 47.4 | 58.5 | 64.0 | 46.8 | 51.5 | 64.2 | 56.4 | 41.0 | 61.2 | 57.4 | - | 34.2 | 34.4 | 46.6 | - | 36.3 | 27.2 | 37.3 | - | 23.7 | 45.0 | 52.2 | - | 53.3 | 55.9 | 53.8 | - | 48.3 | 45.9 | 53.2 | - | 54.9 | 52.8 | - |
DIO |
166.7 | 197.0 | - | 189.3 | 205.9 | 220.7 | - | 217.9 | 184.0 | 198.5 | - | 86.3 | 79.8 | 144.6 | - | 79.7 | 86.6 | 103.2 | - | 92.9 | 110.3 | 134.1 | - | 115.4 | 107.9 | 141.5 | - | 129.1 | 140.3 | 171.6 | - | 91.1 | 147.0 | 133.1 | - | 75.2 | 69.9 | 139.9 | - | 129.4 | 111.7 | 135.9 | - | 70.7 | 162.4 | 132.5 | - | 109.8 | 110.8 | 121.9 | - | 122.5 | 116.3 | 129.9 | - | 135.3 | 132.3 | - |
DPO |
48.1 | 51.8 | - | 31.9 | 31.4 | 32.4 | - | 41.2 | 38.5 | 43.0 | - | 17.7 | 26.1 | 51.4 | - | 31.5 | 35.5 | 31.4 | - | 24.9 | 29.5 | 37.8 | - | 34.2 | 32.0 | 33.6 | - | 25.2 | 27.3 | 45.0 | - | 31.5 | 50.8 | 46.7 | - | 27.4 | 25.5 | 38.5 | - | 27.2 | 23.5 | 51.2 | - | 41.7 | 91.1 | 61.9 | - | 40.5 | 40.9 | 38.3 | - | 31.9 | 30.3 | 33.3 | - | 34.2 | 33.4 | - |
Operating Cycle |
229.9 | 261.3 | - | 250.9 | 262.7 | 275.4 | - | 282.3 | 238.9 | 259.6 | - | 107.3 | 105.5 | 190.7 | - | 124.3 | 133.7 | 151.8 | 51.3 | 138.6 | 178.1 | 196.6 | 55.6 | 166.9 | 155.3 | 200.1 | 64.0 | 175.9 | 191.8 | 235.8 | 56.4 | 132.0 | 208.2 | 190.5 | - | 109.4 | 104.3 | 186.6 | - | 165.8 | 138.8 | 173.2 | - | 94.4 | 207.4 | 184.7 | - | 163.1 | 166.8 | 175.7 | - | 170.8 | 162.1 | 183.1 | - | 190.2 | 185.1 | - |
Cash Conversion Cycle |
181.8 | 209.6 | - | 219.1 | 231.3 | 243.0 | - | 241.1 | 200.4 | 216.7 | - | 89.6 | 79.4 | 139.3 | - | 92.9 | 98.2 | 120.3 | 51.3 | 113.7 | 148.6 | 158.8 | 55.6 | 132.7 | 123.3 | 166.4 | 64.0 | 150.8 | 164.4 | 190.8 | 56.4 | 100.5 | 157.4 | 143.8 | - | 82.0 | 78.8 | 148.1 | - | 138.5 | 115.3 | 122.0 | - | 52.7 | 116.3 | 122.8 | - | 122.6 | 125.8 | 137.4 | - | 138.9 | 131.9 | 149.8 | - | 156.0 | 151.6 | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company Cognex Corporation, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Financial Ratios of other stocks in the Scientific technical instruments industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
|
FLIR Systems, Inc.
FLIR
|
- | - | $ 7.56 B | ||
|
Bonso Electronics International
BNSO
|
- | -5.08 % | $ 5.44 M | ||
|
CyberOptics Corporation
CYBE
|
- | - | $ 401 M | ||
|
Keysight Technologies
KEYS
|
$ 208.61 | -2.58 % | $ 36.3 B | ||
|
Image Sensing Systems, Inc.
ISNS
|
- | 2.38 % | $ 34.5 M | ||
|
MTS Systems Corporation
MTSC
|
- | - | $ 1.14 B | ||
|
Electro-Sensors
ELSE
|
$ 4.55 | - | $ 15.6 M | ||
|
FARO Technologies
FARO
|
- | - | $ 842 M | ||
|
Genasys
GNSS
|
$ 2.11 | -1.86 % | $ 93.5 M | ||
|
ESCO Technologies
ESE
|
$ 204.56 | -0.96 % | $ 5.28 B | ||
|
Fortive Corporation
FTV
|
$ 54.8 | -1.19 % | $ 19.1 B | ||
|
Garmin Ltd.
GRMN
|
$ 208.38 | -0.72 % | $ 40 B | ||
|
Itron
ITRI
|
$ 96.3 | -2.0 % | $ 4.37 B | ||
|
MIND Technology
MIND
|
$ 8.51 | -2.43 % | $ 34.7 K | ||
|
Mesa Laboratories
MLAB
|
$ 78.03 | -0.73 % | $ 423 M | ||
|
MicroVision
MVIS
|
$ 0.94 | -3.98 % | $ 172 M | ||
|
Novanta
NOVT
|
$ 118.31 | -1.59 % | $ 4.25 B | ||
|
Luna Innovations Incorporated
LUNA
|
- | -58.85 % | $ 27.4 M | ||
|
MKS Instruments
MKSI
|
$ 154.4 | -7.44 % | $ 10.4 B | ||
|
Schmitt Industries
SMIT
|
- | 10.39 % | $ 1.62 M | ||
|
Sensata Technologies Holding plc
ST
|
$ 34.65 | -3.75 % | $ 5.21 B | ||
|
Teledyne Technologies Incorporated
TDY
|
$ 517.43 | -1.08 % | $ 24.4 B | ||
|
Trimble
TRMB
|
$ 80.72 | -3.15 % | $ 19.8 B | ||
|
Velodyne Lidar
VLDR
|
- | - | $ 300 M | ||
|
Vontier Corporation
VNT
|
$ 37.06 | -0.27 % | $ 5.66 B | ||
|
Vishay Precision Group
VPG
|
$ 38.15 | -2.15 % | $ 509 M | ||
|
Energous Corporation
WATT
|
$ 5.31 | -1.39 % | $ 38 M |